Global Autoimmune Diseases Drugs Market to grow at a CAGR of 5.57% during the period 2016 - 2020; Finds New Report

Report forecast the global autoimmune diseases drugs market to grow at a CAGR of 5.57% during the period 2016-2020.

Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidneys, glands, and joints.

Autoimmune diseases occur due to genetic, infectious, or environmental factors. There are over 80 autoimmune diseases, including AS, IBD (CD and UC), MS, RA, SLE, and PsA. DMARDs, NSAIDs, corticosteroids, analgesics, and immunosuppressants are the major drug classes used to treat autoimmune diseases.

The report covers the present scenario and the growth prospects of the global autoimmune diseases drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of autoimmune diseases.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, the clinical pipeline for autoimmune diseases drugs is strong, with more emerging therapies, featuring candidates in different stages of development, including advanced drugs with disease-modifying properties and better safety and efficacy profiles. Some promising drugs being developed to treat autoimmune diseases are sirukumab by Johnson & Johnson, tocilizumab by Genentech, biosimilar rituximab by Sandoz, and biosimilar adalimumab by Pfizer. These drugs are in the Phase III stage of development and form a strong pipeline for autoimmune diseases. The approval of promising pipeline candidates during the forecast period is expected to propel the market.

Further, the report states that patent expiries result in the loss of exclusivity of that specific drug, leading to a rapid decline in its sales.

Global Autoimmune Diseases Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Autoimmune Drugs Market: AbbVie Inc., Amgen Inc., Biogen, F. Hoffmann-La Roche, Johnson & Johnson Private Limited, and Pfizer Inc.

Other Prominent Vendors in the market are: Ablynx, AB Science, Acorda Therapeutics, Alder BioPharmaceuticals, Antares Pharma, Astellas Pharma, AstraZeneca, Baxter, Boehringer Ingelheim, Can-Fite BioPharma, Celgene, Celltrion, ChemoCentryx, Coherus BioSciences, Daiichi Sankyo, Eisai, Eli Lilly, Gilead Sciences, GSK, Hospira, Idera Pharmaceuticals, Immunomedics, ImmuPharma, Incyte, Invion, KaloBios Pharmaceuticals, Lexicon Pharmaceuticals, Merck, MedImmune, Morphotek, Novo Nordisk, Novartis, Opexa Therapeutics, Principia Biopharma, Regeneron Pharmaceuticals, Sandoz, Sanofi, Santarus, Takeda Pharmaceuticals, UCB, Vaccinex, Vertex Pharmaceuticals and Vitae Pharmaceuticals.

Market driver

• Promising pipeline
• For a full, detailed list, view our report

Market challenge

• Loss of patent exclusivity of branded therapies
• For a full, detailed list, view our report

Market trend

• Increase in public awareness programs
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 137 pages and 129 Exhibit “Global Autoimmune Drugs Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Disease overview, Pipeline portfolio, Market segmentation by type of disease, Market segmentation by mechanism of action, Market segmentation by drug class, Market segmentation by type of molecule, Market segmentation by ROA, Market segmentation by dosage form, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/Jwv

Find all Pharmacy report at : http://www.marketresearchreports.com/pharmacy